Misleading Google Link Lands Gilead an FDA Untitled Letter

Drug Industry Daily
The FDA has asked Gilead Sciences to remove a sponsored link on Google that misrepresents the drugmaker’s hepatitis B drug, Viread, and omits risk information, the first such enforcement action since the agency issued guidance on character-limited advertisements last month.

To View This Article:


Subscribe To Drug Industry Daily